Advanced glycation end products impair KCa3.1- and K Ca2.3-mediated vasodilatation via oxidative stress in rat mesenteric arteries

Pflugers Archiv European Journal of Physiology

Volumn 466, Issue 2, 2014, Pages 307-317

  Zhao, Li Mei ^a   Wang, Yan ^a   Ma, Xiao Zhen ^a   Wang, Nan Ping ^a   Deng, Xiu Ling ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Advanced glycation end products; Ca2+ activated potassium channels; Oxidative stress; Resistance arteries

Indexed keywords

ALKANES; ANIMALS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MESENTERIC ARTERIES; NG-NITROARGININE METHYL ESTER; OXIDATIVE STRESS; PYRAZOLES; QUINOLINIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; VASODILATION;

EID: 84893864668     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-013-1324-y     Document Type: Article

References (43)

1. Bashan N, Kovsan J, Kachko I, Ovadia H, Rudich A (2009) Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev 89:27-71
2. + channel in renal artery endothelium in situ by nitric oxide and reactive oxygen species. Kidney Int 64:199-207 (Pubitemid 36714172)
3. 1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension. Circulation 119:2323-2332
4. Brondum E, Kold-Petersen H, Simonsen U, Aalkjaer C (2009) NS309 restores EDHF-type relaxation in mesenteric small arteries from type 2 diabetic ZDF rats. Br J Pharmacol 159:154-165
5. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH (2002) EDHF: bringing the concepts together. Trends Pharmacol Sci 23:374-380
6. Bychkov R, Pieper K, Ried C, Milosheva M, Bychkov E, Luft FC, Haller H (1999) Hydrogen peroxide, potassium currents, and membrane potential in human endothelial cells. Circulation 99:1719-1725 (Pubitemid 29162485)
7. + channel-dependent EDHF responses in type II diabetic ZDF rats. Br J Pharmacol 148:434-441 (Pubitemid 43882079)
8. Ca channel of intermediate conductance in bovine aortic endothelial cells. J Membr Biol 158:147-158 (Pubitemid 27337005)
9. Ding H, Hashem M, Wiehler WB, Lau W, Martin J, Reid J, Triggle C (2005) Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse. Br J Pharmacol 146:1110-1118 (Pubitemid 41785322)
10. Ca3.1-channels during EDHF signaling in mesenteric resistance arteries. Circ Res 102:1247-1255
11. + channels to reactive oxygen species. Proc Natl Acad Sci U S A 92:11796-11800 (Pubitemid 26014200)
12. Edwards G, Feletou M, Weston AH (2010) Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflugers Arch 459:863-879
13. +-channels suppresses EDHF-mediated vasodilation. Br J Pharmacol 138:594-601 (Pubitemid 36315307)
14. Endemann DH, Schiffrin EL (2004) Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus. Curr Hypertens Rep 6:85-89 (Pubitemid 39359547)
15. Félétou M, Vanhoutte PM (2009) EDHF: an update. Clin Sci (Lond) 117:139-155
16. Gao X, Zhang H, Schmidt AM, Zhang C (2008) AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 295:H491-H498
17. Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced glycaton end products: sparking the development of diabetic vascular injury. Circulation 114:597-605 (Pubitemid 44199649)
18. + channels in normal and impaired EDHF-dilator responses-relevance to cardiovascular pathologies and drug discovery. Br J Pharmacol 157:509-526
19. Hartge MM, Kintscher U, Unger T (2006) Endothelial dysfunction and its role in diabetic vascular disease. Endocrinol Metab Clin North Am 35:551-560 (Pubitemid 44310913)
20. He M, Siow RC, Sugden D, Gao L, Cheng X, Mann GE (2011) Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes. Nutr Metab Cardiovasc Dis 21:277-285
21. Kourie JI (1998) Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol 275:C1-C24
22. Lee JJ, Hsiao CC, Yang IH, Chou MH, Wu CL, Wei YC, Chen CH, Chuang JH (2012) High-mobility group box 1 protein is implicated in advanced glycation end products-induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5. Mol Vis 18:838-850
23. Leo CH, Hart JL, Woodman OL (2011) Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin- induced diabetes. Br J Pharmacol 162:365-377
24. Li R, McCourt P, Schledzewski K, Goerdt S, Moldenhauer G, Liu X, Smedsrød B, Sørensen KK (2009) Endocytosis of advanced glycation end-products in bovine choriocapillaris endothelial cells. Microcirculation 16:640-655
25. Mamputu JC, Renier G (2004) Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants. J Leukoc Biol 75:1062-1069 (Pubitemid 38720648)
26. McPherson GA (1992) Assessing vascular reactivity of arteries in the small vessel myograph. Clin Exp Pharmacol Physiol 19:815-825 (Pubitemid 23000153)
27. Morikawa K, Matoba T, Kubota H, Hatanaka M, Fujiki T, Takahashi S, Takeshita A, Shimokawa H (2005) Influence of diabetes mellitus, hypercholesterolemia, and their combination on EDHF-mediated responses in mice. J Cardiovasc Pharmacol 45:485-490 (Pubitemid 40627969)
28. + channels in urinary bladder smooth muscle cells. J Pharmacol Sci 100:237-241
29. Negre-Salvayre A, Salvayre R, Augé N, Pamplona R, Portero-Otín M (2009) Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal 11:3071-3109
30. Rahman S, Rahman T, Ismail AA, Rashid AR (2007) Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab 9:767-780 (Pubitemid 47555200)
31. Sena CM, Matafome P, Crisóstomo J, Rodrigues L, Fernandes R, Pereira P, Seiça RM (2012) Methylglyoxal promotes oxidative stress and endothelial dysfunction. Pharmacol Res 65:497-506
32. Ca channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar vasodilation. FASEB J 23:1138-1145
33. + channel. Circ Res 99:537-544 (Pubitemid 44337826)
34. 3) channels modulates arterial tone and blood pressure. Circ Res 93:124-131 (Pubitemid 36919699)
35. Tokube K, Kiyosue T, Arita M (1996) Openings of cardiac KATP channel by oxygen free radicals produced by xanthine oxidase reaction. Am J Physiol 27:H478-H489
36. Vanhoutte PM, Shimokawa H, Tang EHC, Feletou M (2009) Endothelial dysfunction and vascular disease. Acta Physiol 196:193-222
37. Vlassara H, Uribarri J, Cai W, Striker G (2008) Advanced glycation end product homeostasis: exogenous oxidants and innate defenses. Ann NY Acad Sci 1126:46-52 (Pubitemid 351589317)
38. Wang CY, Liu HJ, Chen HJ, Lin YC, Wang HH, Hung TC, Yeh HI (2011) AGE-BSA down-regulates endothelial connexin43 gap junctions. BMC Cell Biol 12:19. doi: 10.1186/1471-2121-12-19
39. 2+-sensing receptors in rat mesenteric artery; comparative studies using a model of type II diabetes. Br J Pharmacol 154:652-662 (Pubitemid 351744940)
40. Wigg SJ, Tare M, Tonta MA, O'Brien RC, Meredith IT, Parkington HC (2001) Comparison of effects of diabetes mellitus on an EDHF dependent and an EDHF- independent artery. Am J Physiol Heart Circ Physiol 281:H232-H240
41. Wulff H, Castle NA (2010) Therapeutic potential of KCa3.1 blockers: recent advances and promising trends. Expert Rev Clin Pharmacol 3:385-396
42. Yamagishi S, Nakamura K, Imaizumi T (2005) Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev 1:93-106
43. Ca3.1 channels. Pflugers Arch 464:613-621